-+ 0.00%
-+ 0.00%
-+ 0.00%

Entrada Therapeutics Advances ELEVATE-44-201 Study to Higher Dose for Duchenne Muscular Dystrophy

Reuters·02/17/2026 12:00:43

Please log in to view news